SE7514601L - Skyddande pertussis-antigen och forfarande for dess framstellning samt medel som innehaller antigenet - Google Patents

Skyddande pertussis-antigen och forfarande for dess framstellning samt medel som innehaller antigenet

Info

Publication number
SE7514601L
SE7514601L SE7514601A SE7514601A SE7514601L SE 7514601 L SE7514601 L SE 7514601L SE 7514601 A SE7514601 A SE 7514601A SE 7514601 A SE7514601 A SE 7514601A SE 7514601 L SE7514601 L SE 7514601L
Authority
SE
Sweden
Prior art keywords
preparation
antigenet
procedures
pertussis antigen
protective
Prior art date
Application number
SE7514601A
Other languages
English (en)
Other versions
SE431057B (sv
Inventor
T B Helting
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of SE7514601L publication Critical patent/SE7514601L/sv
Publication of SE431057B publication Critical patent/SE431057B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
SE7514601A 1974-12-24 1975-12-23 Forfarande for framstellning av ett skyddande antigen ur bordetella pertussis SE431057B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2461439A DE2461439C3 (de) 1974-12-24 1974-12-24 Verfahren zur Herstellung eines schützenden Antigens von Bordetella Pertussis sowie jenes enthaltendes Mittel

Publications (2)

Publication Number Publication Date
SE7514601L true SE7514601L (sv) 1976-06-25
SE431057B SE431057B (sv) 1984-01-16

Family

ID=5934586

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7514601A SE431057B (sv) 1974-12-24 1975-12-23 Forfarande for framstellning av ett skyddande antigen ur bordetella pertussis

Country Status (17)

Country Link
US (1) US4029766A (sv)
JP (1) JPS6222970B2 (sv)
AT (1) AT355203B (sv)
BE (1) BE837082A (sv)
CA (1) CA1059027A (sv)
CH (1) CH628246A5 (sv)
DE (1) DE2461439C3 (sv)
DK (1) DK143317C (sv)
ES (1) ES443624A1 (sv)
FR (1) FR2295758A1 (sv)
GB (1) GB1537849A (sv)
IE (1) IE42622B1 (sv)
IL (1) IL48730A (sv)
LU (1) LU74088A1 (sv)
MX (1) MX3785E (sv)
NL (1) NL7514858A (sv)
SE (1) SE431057B (sv)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2393065A1 (fr) * 1977-05-31 1978-12-29 Merieux Inst Procede de separation de lipides d'endotoxines bacteriennes et notamment d'endotoxine de bordetella pertussis
IT1107772B (it) * 1977-08-22 1985-11-25 Cancer Res Inst Royal Procedimento per la produzione di complessi macromolecolari prodotto ottenuto e composizioni farmaceutiche che lo contengono come ingrediente attivo
US4196192A (en) * 1977-10-28 1980-04-01 American Cyanamid Company Combined Haemophilus influenzae type b and pertussis vaccine
NZ188211A (en) * 1977-10-28 1984-09-28 American Cyanamid Co Isolation of polyribosyl ribitol phosphate(prp)from haemophilus influenzae type b;vaccine comprising prp and bordetellapertussis antigens
DE2961293D1 (en) * 1978-02-17 1982-01-14 Nat Res Dev Immunogenic cell envelope preparations
US4247452A (en) * 1978-03-01 1981-01-27 The Secretary Of State For Defence In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland Purification of pertussis haemagglutinins
DE3043291A1 (de) * 1980-11-17 1982-07-01 Dso Pharmachim Vakzine gegen keuchhusten
GB2144129B (en) * 1981-08-24 1985-10-09 Vilas V Likhite Antigens as immunostimulant adjuvants
HU188847B (en) * 1983-02-22 1986-05-28 Human Oltoanyagtermeloe Es Kutato Intezet,Hu Process for producing liophylized combined vaccines
US4705686A (en) * 1986-05-09 1987-11-10 American Cyanamid Process for the preparation of acellular Bordetalla pertussis vaccine
US4845036A (en) * 1987-02-03 1989-07-04 The United States Of America As Represented By The Department Of Health And Human Services Process for isolation of the B oligomer of pertussis toxin
CA1337859C (en) * 1987-04-24 1996-01-02 Masashi Chazono Method for culturing bordetella pertussis, a pertussis toxoid and a pertussis vaccine
US5139776A (en) * 1987-04-24 1992-08-18 The Research Foundation For Microbial Diseases Of Osaka University Method for culturing Bordetella pertussis, a pertussis toxoid and a pertussis vaccine
GB9924351D0 (en) 1999-10-14 1999-12-15 Brennan Frank Immunomodulation methods and compositions
WO2009014782A2 (en) * 2007-04-27 2009-01-29 Dow Global Technologies Inc. Improved production and in vivo assembly of soluble recombinant icosahedral virus-like particles

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3141824A (en) * 1961-05-19 1964-07-21 Lilly Co Eli Pertussis antigen
US3395219A (en) * 1964-12-11 1968-07-30 Merck & Co Inc Process for production of pertussis antigen
US3405218A (en) * 1965-09-22 1968-10-08 Parke Davis & Co Extracting bordetella pertussis antigens with lithium bromide
US3465078A (en) * 1965-10-21 1969-09-02 Sydney Z Spiesel Method of recovering antigens from bordetella pertussis cells

Also Published As

Publication number Publication date
ATA980275A (de) 1979-07-15
NL7514858A (nl) 1976-06-28
BE837082A (fr) 1976-06-24
SE431057B (sv) 1984-01-16
IE42622B1 (en) 1980-09-10
FR2295758A1 (fr) 1976-07-23
LU74088A1 (sv) 1976-11-11
DE2461439B2 (de) 1979-07-12
MX3785E (es) 1981-07-16
CA1059027A (en) 1979-07-24
CH628246A5 (de) 1982-02-26
AU8780875A (en) 1977-06-30
DK586575A (da) 1976-06-25
IE42622L (en) 1976-06-24
JPS5188623A (sv) 1976-08-03
FR2295758B1 (sv) 1979-06-29
DE2461439C3 (de) 1980-03-20
US4029766A (en) 1977-06-14
DK143317B (da) 1981-08-10
AT355203B (de) 1980-02-25
JPS6222970B2 (sv) 1987-05-20
IL48730A0 (en) 1976-02-29
GB1537849A (en) 1979-01-04
IL48730A (en) 1978-10-31
DK143317C (da) 1981-12-28
DE2461439A1 (de) 1976-07-01
ES443624A1 (es) 1977-04-16

Similar Documents

Publication Publication Date Title
SE7514601L (sv) Skyddande pertussis-antigen och forfarande for dess framstellning samt medel som innehaller antigenet
NL7513252A (nl) Afdruklepel voor tandartsdoeleinden.
ES500567A0 (es) Procedimiento de preparar complejos vacunantes por reaccion de arn ribonosales y de antigenos especificos.
NL186442C (nl) Klep voor aerosolhouder.
DK152742C (da) Rynket emballeringshylster, isaer poelseskind samt fremgangsmmaade og apparat til fremstilling af dette.
NL7509136A (nl) Werkwijze ter bereiding van preparaten tegen infectieziekten, alsmede als zodanig verkregen preparaten.
BG25643A3 (bg) Метод за извличане на изопрен от смеси,които го съдържат
YU35338B (en) Process for obtaining optical enatiomers of delta 1 -t.butyl-aminomethyl-4-hydroxy-m-xylene-delta 1, delta 3 - diols
NL7504335A (nl) Werkwijze voor de behandeling van glazen houders.
DK132375B (da) Di-(3-carboxy-2,4,6-triiodanilider) til anvendelse som røntgenkontrastmiddel.
NL7514014A (nl) Werkwijze ter bereiding van een bofvaccine.
NL7510120A (nl) Werkwijze voor de bereiding van een vaccin tegen ingewandsstoornissen.
PH14458A (en) Process for isolating the immunogenic components of influenza viruses
NL7501125A (nl) Extractiebuis voor polyamiden.
SE7910089L (sv) Vacciner
NL7810753A (nl) Gecombineerd vaccin voor immunisering tegen infecties door haemophilus influenza, type b.
NL7501114A (nl) Werkwijze voor de bereiding van n,n-diallyl- orraceetamide.
CH430949A (fr) Procédé de préparation d'un vaccin antigène
SE7507667L (sv) Sett att framstella 2-substituerade 5-oxo-5h-dibenso (a,d)-cukloheptener och anvendning derav som lekemedel
SE7708693L (sv) Atoxisk, immunogen produkt ur tetanus-toxin
SE387959B (sv) Sett att sterilitetsprova antigenhaltiga produkter, serskilt vacciner, innehallande timerosal, jemte tillvextmedium for genomforande av settet
CH554850A (de) Verfahren zur herstellung von bis-(4-unsubstituiertenamino- oder 4-mono- oder disubstituierten-amino-3,5dinitrophenyl)-disulfiden.
SE7406704L (sv) Sett och autoklav for angsterilisering.
NL7408445A (nl) Werkwijze voor de bereiding van een metaan bevattend gas.
AR205836A1 (es) Procedimiento para la preparacion de un producto constituido por fracciones antigenas de origen bacteriano

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7514601-9

Effective date: 19891128

Format of ref document f/p: F